Jiangyin, China · Founded 2009 · In IPO Registration
Developer and manufacturer of novel antimicrobial peptide drugs and therapeutic candidates designed for drug-resistant infections, metabolic disorders, and autoimmune diseases. Protelight Pharmaceuticals is based in Jiangyin, China and was founded in 2009. Its last reported valuation was $352 million in Nov 2025. It has raised $115 million.
Last reported valuation
$351.9M
Oct 2026
Priced at
—
Total raised
$115.0M
Last round
—
Team — not yet on record
No current team members for Protelight Pharmaceuticals are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Protelight Pharmaceuticals with a free account
·The complete investor list: 12 names
·Watch Protelight Pharmaceuticals: the Monday email on marks, rounds and moves
